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Multiple Mitochondrial Dysfunction Syndrome (MMDS) comprises a group of severe
autosomal recessive diseases with onset in early infancy and characterized by a
systemic disorder of energy metabolism, resulting in weakness, respiratory failure,
lack of neurological development, lactic acidosis, and early death. Biochemical findings
include defects of complexes I, II, and III of the mitochondrial respiratory chain and
severe deficiency of Pyruvate dehydrogenase complex (PDHc). Three genes have been
associated with MMDS since now: NFU1, BOLA3, and IBA57. We describe an Italian
male patient presenting with severe psychomotor regression after an infectious episode,
lactic acidosis, hyperglycinemia, reduction of respiratory chain complex II associated with a
marked deficiency of PDHc activity. He carried two heterozygous mutations in NFU1, one
novel (p.Cys210Phe) and one previously reported (p.Gly189Arg) missense change affecting
highly conserved residues. A severe leukoencephalopathy with cavitations in deep white
matter was disclosed at brain MRI, suggesting a peculiar neuroradiological phenotype
associated with defect in this gene.
Keywords: leukoencephalopathy, multiple mitochondrial dysfunction syndrome, MMDS1, NFU1, mitochondrial
disorders, brain MRI
INTRODUCTION
Multiple Mitochondrial Dysfunction Syndrome (MMDS) is a
severe autosomal recessive disease with onset in early infancy.
It is characterized by a systemic disorder of energy metabolism
resulting in marked impairment of neurologic development, with
diffuse weakness, respiratory failure, lactic acidosis, and early
death (Seyda et al., 2001; Roualt and Tong, 2008). MMDS has
been associated with mutations in NFU1 (causing MMDS1,
MIM#605711), BOLA3 (causing MMDS2, MIM#614299) and
IBA57 (causing MMDS3, MIM#615330) (Cameron et al., 2011;
Navarro-Sastre et al., 2011; Ajit Bolar et al., 2013), all genes
coding proteins with a role in iron-sulfur (Fe-S) cluster biosyn-
thesis. Defects in this pathway, comprising alsomutations in ISCU
(MIM#255125) (Mochel et al., 2008), lead to abnormal function
of many proteins containing Fe-S centers, including mitochon-
drial respiratory chain (MRC) complexes I, II, and III, and lipoic
acid synthase (LIAS). The latter enzyme is needed for the matura-
tion of four mitochondrial lipoate-dependent enzymes: pyruvate
dehydrogenase complex (PDHc), α-ketoglutarate dehydrogenase
(α-KGDH), branched-chain ketoacid dehydrogenase (BCKDH)
and the H protein of the glycine cleavage system (MIM∗238330)
(Roualt and Tong, 2008; Stehling et al., 2014). Interestingly, muta-
tions in LIAS cause Pyruvate dehydrogenase lipoic acid synthetase
deficiency (MIM#614462), a syndrome characterized by several
biochemical and clinical features overlapping with MMDS (Mayr
et al., 2011).
NFU1 is a Fe-S cluster scaffold, initially considered as an
alternative scaffold to ISCU, while recently characterized as a
late targeting factor of Fe-S clusters, specifically required for the
proper assembly of only a subset of (4Fe4S) proteins includ-
ing LIAS and subunits of MRC complexes I and II (Cameron
et al., 2011; Navarro-Sastre et al., 2011; Stehling et al., 2014).
Since now three reports have described 14 patients belonging
to 11 families with NFU1 mutations (Cameron et al., 2011;
Navarro-Sastre et al., 2011; Nizon et al., 2014): most cases pre-
sented with infantile encephalopathy associate with pulmonary
hypertension, lactic acidosis, hyperglycinemia and severe regres-
sion leading to death before the age 15 months (Cameron et al.,
2011; Navarro-Sastre et al., 2011). Only one child survived until
the age of 2½ years (Nizon et al., 2014); leukoencephalopathy
at brain MRI, has been illustrated only in this last patient, and
reported without documentation in an additional case. Ten indi-
viduals from Spanish and French families were homozygous for
p.Gly208Cys mutation, suggesting a founder effect in Europe.
Other three mutations have been described in the remaining
cases.
We describe the first Italian patient affected by MMDS1 asso-
ciated with two heterozygous mutations in NFU1.
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BACKGROUND
CASE REPORT
The proband was the first child born from unrelated Italian
parents. Family history was negative; pregnancy and delivery
were uneventful. Psychomotor development was referred nor-
mal until 7 months of age. During a mild febrile illness, he
presented severe and rapid psychomotor regression, loosing sit-
ting position and smiling, and developed spastic tetraparesis.
Metabolic exams revealed high plasma lactate (5620mmol/L; nv
580–2100mmol/L) and pyruvate levels (294mmol/L; nv 55–145),
abnormal urinary excretion of lactic, succinic, fumaric, and glu-
taric acids; plasma amino acids analysis disclosed elevation of
glycine (589mmol/l, nv 11–360). Brain MRI showed the presence
of a diffuse and symmetric involvement of hemispheric white
matter with more marked abnormalities in the deep white mat-
ter that presented also cavitations (Figure 1). The cerebellum,
brainstem and basal ganglia had normal appearance, while spec-
troscopy revealed a peak of lactic acid and decreased N-acetyl
Aspartate/creatine ratio.
The neurological examination at 9 months revealed low body
weight and height (10–25 centiles) with normal head circumfer-
ence (50–75 centiles). He had good visual contact and response
to sound, severe spasticity, absence of head and trunk control,
dystonic postures, and frequent crying. Electroencephalogram
showed a poor organization without epileptic abnormalities.
Electrocardiogram was normal and pulmonary hypertension
was never detected. A mitochondrial disease was suspected and
he underwent muscle and skin biopsies.
Despite the beginning of treatment with vitamin B2, B1, and
Coenzyme Q the child further deteriorated during the following
months: he suffered from several episodes of metabolic decom-
pensation, developed epileptic seizures and required nasogastric
feeding tube. He died at 18 months of age during a severe
pneumonia; autopsy was not performed.
Muscle biopsy showed normal histological pictures. The anal-
ysis of MRC complexes activities revealed a clear reduction of
complex II and SDH in muscle (43 and 48% of the control
mean, respectively), and fibroblasts (30 and 55% respectively) and
mild decrease of complex I in muscle (62%), and complex IV in
fibroblasts (62%); the activate form of PDHc was also markedly
reduced in both muscle and fibroblasts (28 and 1% respectively)
(Table 1).
Table 1 | Biochemical activity of respiratory chain complexes and
PDHc activities in muscle and fibroblasts.
Muscle Control range Fibroblasts Control range
Complex I 12.7 13–28 28.1 10.7–26.0
Complex II 9.2 14–29 4.0 8.6–18.4
Complex III 104 65–125 89 70–120
Complex IV 169 130–250 76 95–150
Complex V 156 120–380 100 65–113
SDH 7.1 9.5–20.0 5.7 6.5–14.3
Citrate Synthase* 189 60–160 88 100–200
PDHc 1.21 2.70–6.00 0.27 2.40–3.60
Values under the control range are reported in bold. All enzymatic activities
are normalized for Citrate Synthase activity. *nmol/min mg. SDH, succinate
dehydrogenase; PDHc, pyruvate dehydrogenase complex.
FIGURE 1 | Brain MRI. Axial T2 (A-C) and FLAIR images (D-F) show diffuse hyper intensity of the white matter (A: asterisks) more prominent in the posterior
periventricular and deep regions (A-C: arrows) with evidence of partial cystic degeneration and cavitations in FLAIR sections (D-F: arrows).
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MATERIAL AND METHODS
Informed consent was obtained from patient’s parents, in
agreement with the Declaration of Helsinki and approved
by the Ethical Committees of the Foundation IRCCS Istituto
Neurologico “C. Besta,” Milan, Italy.
Biochemical studies
Skeletal muscle and skin biopsies were performed according to
standard protocols. The measurement of MRC complexes activ-
ities was performed using standard spectrophotometric tech-
niques (Bugiani et al., 2004) in both muscle homogenate and
cultured skin fibroblasts, and normalized to citrate synthase (CS)
activity, an index of mitochondrial content in the analyzed speci-
mens. PDHc assay was performed with radioactive method (Uziel
et al., 1988).
Molecular studies
DNA was extracted from peripheral blood of the patient and
their parents using standard methods. The coding sequence and
flanking intronic regions of NFU1 were analyzed by PCR ampli-
fication using the primers reported in Supplementary Table 1.
Amplicons were stained with ethidium bromide on 2% agarose
gels, cycle-sequenced using BigDye chemistry 3.1, and run on an
ABI 3130XL automatic sequencer (Applied Biosystems).
Western-Blot analysis
Approximately 2 × 106 fibroblasts were trypsinized, pelleted,
sonicated, solubilized with 10mM phosphate pH 7.2, 10mM
EDTA, 150mM NaCl, 2% Triton X-100 and 0.25% SDS, in
presence of a mixture of protease inhibitors, and centrifuged
at 100,000 g for 30min at 4◦C. A 50μg aliquot of protein per
lane was then electrophoresed through an SDS-polyacrylamide
gel. The gel was then electroblotted for 90min onto a nitrocel-
lulose filter. The latter was incubated with 5% non-fat milk in
20mM Tris pH 8.0, 150mM NaCl, 0.1% Tween-20 (MTT) for
60min at room temperature followed by incubation overnight
at 4◦C with primary antibody. After four washing in MTT the
filter was incubated for 60min at room temperature with a
goat anti-rabbit/mouse IgG conjugated to horseradish peroxi-
dase (HRP) (1:5000 in MTT). After four additional washing, the
peroxidase reaction was revealed by autoradiography using the
chemiluminescence ECL kit (GE Healthcare). The following pri-
mary antibody, diluted in MTT, were used: α-NFU1 (Biorbyt,
1:50), α-NDUFA9 (subunit of complex I; Mitoscience, 1:2000),
α-SDHA (subunit of complex II; Mitoscience, 1:10,000), α-
SDHB (subunit of complex II; Mitoscience, 1:200), α-UQCRFS1
(subunit of complex III; Mitoscience, 1:1000), α-MTCO2 (sub-
unit of complex IV; Mitoscience, 1:1500), α-COX4 (subunit
of complex IV; Mitoscience, 1:2000), α-Tubulin beta (Sigma,
1:2000).
GENETIC AND BIOCHEMICAL RESULTS
The genetic analysis of NFU1 showed the presence of
two heterozygous mutations, c.565G>A and c.629G>T
(NM_001002755.2), causing the p.Gly189Arg and p.Cys210Phe
changes in the protein amino acid sequence (NP_001002755.1)
(Figure 2A). Segregation analysis confirmed that the first muta-
tion was inherited from the mother and the second from the
father. The two identified nucleotide substitutions were not
reported in public databases, including dbSNPs and NHLBI
Exome Sequencing Project. The two affected amino acids are
conserved in several species (Figure 2B) and the amino acid
changes have high scores for pathogenicity according to different
bioinformatic tools.
Western blot analysis performed on patient’s fibroblasts
showed no reduction of NFU1 protein; however, we found a par-
tial reduction of the subunits of complex II, SDHA (70 kDa),
and SDHB (30 kDa), whereas the amount of subunits belong-
ing to other MRC complexes were similar to control levels
(Figure 2C), using β-tubulin as loading control. These findings
are in agreement with those recently reported by Ferrer-Cortes
et al. (2013).
DISCUSSION
REVIEW SIMILAR CASES
In 2001, Seyda et al. (2001) reported on three siblings, born
from non-consanguineous parents of Mexican descent, affected
with metabolic acidosis and high lactate levels, feeding diffi-
culty, weakness and lethargy present since few days after birth;
all three babies died within the first month of life. Biochemical
studies demonstrated a combined defect of PDHc, MRC com-
plex II, complex I + III, and complex II + III in fibroblasts from
all patients. Laboratory investigations showed lactic acidosis and
elevated levels of serum glycine.
Ten years later, next-generation sequencing (NGS) allowed
Cameron et al. (2011) to detect a homozygous missense mutation
(c.545G>A; p.Arg182Gln) in exon 6 of NFU1 in these previously
reported patients. Contemporary, Navarro-Sastre et al. (2011)
reported ten individuals from nine unrelated Spanish families
affected with fatal MMDS and carrying mutations in NFU1 gene.
In all patients the onset of symptoms started in the first months
of life, and all died before the age of 16 months. They presented
with failure to thrive, pulmonary hypertension, and neurologi-
cal regression. For 3/13 published cases brain imaging data were
available, and in only one case the presence of leukodystrophy was
reported; the others were described with normal MRI pattern or
unspecific and inconsistent features (e.g., cerebral atrophy, cere-
bellar lesions). However, white-matter necrosis with preservation
of U fibers or areas of white-matter demyelination and vac-
uolization were found in cases in which autopsy was performed
(Seyda et al., 2001; Navarro-Sastre et al., 2011). The biochem-
ical phenotype included metabolic acidosis with variable lactic
acidemia and hyperglycinemia, and high urinary excretion of
2-ketoglutaric, 2-ketoadipic, 2-hydroxyadipic, and glutaric acid.
In the cases where tissues were available, activity of the glycine
cleavage system in liver was low or undetectable. PDHc activ-
ity in fibroblasts was also decreased. The rates of 14C-substrate
oxidation (pyruvate, leucine, and glutamate) in fibroblasts were
low. Only in 3 patients MRC enzyme activities were assessed in
frozen muscle, and a reduction of complex II + III activity (26–
43% of control value) was detected. Genetic studies of NFU1 in
these patients showed the same c.622G>T/p.Gly208Cys muta-
tion in exon 7 (9/10 homozygous, 1/10 heterozygous) and an
additional intronic mutation c.545 + 5G>A affecting the donor
splice-site of exon 6 (1/10 heterozygous). Recently, a further case
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FIGURE 2 | Genetic studies and protein characterization in fibroblasts.
(A) Chromatograms of the NFU1 genomic regions comprising the
identified variant in the patient (Pt, lower panel) and in a control subject
(Ct, upper panel). (B) Multiple alignment of NFU1 protein domain
containing mutations. Both mutations affect highly conserved amino acids
and the Cys210Phe strikes the first cysteine of the CXXC motif that is a
characteristic binding domain for Fe-S cluster. (C) SDS-gel electrophoresis
and Western blot analysis of fibroblasts from patient (Pt) and two
controls (Ct). We used antibodies against NFU1; NDUFA9 (subunit of
complex I); SDHA and SDHB (subunits of complex II); UQCRFS1 (subunit
of complex III); MTCO2 and COX4 (subunits of complex IV); and
β-Tubulin (as loading control).
was reported by Nizon et al. (2014), a French female with nor-
mal psychomotor development until 14 months of age, when she
showed progressively losing of standing and sitting abilities with
failure to thrive and pulmonary hypertension; then she developed
a severe spastic tetraparesis associated with extrapyramidal signs.
Lactate and pyruvate levels resulted within normal values, except
during two episodes of metabolic decompensation. Glycine lev-
els were high in plasma, urine and CSF, and urinary organic acid
analysis showed mildly increased excretion of glutaric acid, 2-
hydroxyglutaric acid and α-ketoglutaric acid. Fibroblasts analysis
demonstrated a defect of PDHc activity (25%) and of complex II
(28%). Brain MRI revealed the presence of leukoencephalopathy
involving periventricular white matter and corpus callosum, that
were partially cystic.
The clinical, biochemical and genetic data of the previous and
present cases are reported in Table 2.
NFU1 is required for efficient assembly of lipoate synthase and
respiratory complex II (SDH); NFU1 transiently bind the (4Fe–
4S) cluster which may be transferred to the target apoprotein.
The two mutations identified in our patient are both located in a
highly conserved iron sulfur cluster assembly domain; moreover,
the p.Cys210Phe change hits the first cysteine of a CxxC motif
essential for the binding of Fe-S cluster. Although Western Blot
analysis on fibroblasts failed to reveal any reduction of NFU1, the
identified amino acid changes suggest a severe dysfunction of the
protein, confirmed by the biochemical profile identified in our
patients.
The presence of the p.Gly208Cys mutation in ten families from
Spanish and French has suggested a founder effect in Europe
(Navarro-Sastre et al., 2011; Nizon et al., 2014); the p.Gly189Arg
mutation, found in our patient and in a previously described
case (Nizon et al., 2014) can represent a second possible common
European mutation.
The onset of symptoms and the clinical course in our case
were similar to previously described patients, except for absence
of pulmonary hypertension. The presence of abnormal urinary
excretion of lactate and elevated levels of plasma glycine confirm
that they represent the biochemical hallmarks of this syndrome.
Brain MRI pictures have not been fully described in the previ-
ous cases; the presence of white matter abnormalities has been
reported in only one case from Navarro-Sastre series, but no
MRI was available (Navarro-Sastre et al., 2011). Moreover, the
evidence of a leukodystrophy associated with early development
of cavitations in our patient similar to that described in one
patient by Nizon et al. (2014), suggests that this may be the
MRI specific pattern related to MMDS1. Interestingly, cavitating
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leukoencephalopathy represents an increasingly common MRI
finding inmitochondrial disorders due to different genetic defects
(Kashani et al., 2014; Melchionda et al., 2014).
CONCLUDING REMARKS
We have described the first Italian patient affected with MMDS1.
This case contributes to delineate the phenotype associated
with defects in NFU1, represented by severe early onset neu-
rological impairment, multiple defects of respiratory chain and
PDHc, high lactate and glycine levels. Moreover, the presence of
leukodystrophy with cysts or cavitations is probably the common-
est neuroradiological picture in MMDS1 patients.
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